The differential response to immune checkpoint inhibitors in colorectal and endometrial cancer patients according to different mismatch repair alterations.

Authors

Moh'd Khushman

Moh'd M. Khushman

Department of Hematology-Oncology, University of Alabama at Birmingham/O'Neal Comprehensive Cancer Center, Birmingham, AL

Moh'd M. Khushman , Michael Driscoll Toboni , Jia Zeng , Joanne Xiu , Upender Manne , Alex Farrell , Bassel F. El-Rayes , Emil Lou , Anthony Frank Shields , Philip Agop Philip , Mohamed E. Salem , Jim Abraham , David Spetzler , John Marshall , Priya Jayachandran , Michael J. Hall , Heinz-Josef Lenz , Wolfgang Michael Korn , Matthew A. Powell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Other Colorectal and Anal Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3625)

DOI

10.1200/JCO.2022.40.16_suppl.3625

Abstract #

3625

Poster Bd #

418

Abstract Disclosures